These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1662290)

  • 21. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N; Miyakawa Z; Kimura T; Shimizu A; Notake Y; Kunii K
    Drugs; 1995; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract]   [Full Text] [Related]  

  • 22. Lomefloxacin disc susceptibility criteria--a reappraisal.
    Smith JM; Hashmi ZS
    J Antimicrob Chemother; 1990 Jul; 26(1):152-3. PubMed ID: 2211438
    [No Abstract]   [Full Text] [Related]  

  • 23. Lomefloxacin clinical pharmacokinetics.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 25. Initial clinical experience with clinafloxacin in the treatment of serious infections.
    Tack KJ; McGuire NM; Eiseman IA
    Drugs; 1995; 49 Suppl 2():488-91. PubMed ID: 8549411
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
    Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fluoroquinolones].
    Lumio J
    Duodecim; 1991; 107(10):757-64. PubMed ID: 1364719
    [No Abstract]   [Full Text] [Related]  

  • 28. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
    Rossolini GM; Valentini S; Vaiani G; Satta G
    J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fluoroquinolones--a current review].
    Christ W; Kemmler H
    Med Monatsschr Pharm; 2001 Jul; 24(7):215-25. PubMed ID: 11486553
    [No Abstract]   [Full Text] [Related]  

  • 32. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 33. Quinolones in 2005: an update.
    Van Bambeke F; Michot JM; Van Eldere J; Tulkens PM
    Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolones in dermatology.
    Sable D; Murakawa GJ
    Dis Mon; 2004 Jul; 50(7):381-94. PubMed ID: 15280869
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

  • 36. [How can we protect against broad-band pathogens? The situation with quinolone resistance].
    Kresken M; Hafner D
    Pharm Unserer Zeit; 2001; 30(5):436-45. PubMed ID: 11575181
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility pattern of bacterial isolates to lomefloxacin.
    Lalitha MK; Nisha AK; Bhattacharya SS; Ramamoorthy U; Lal HM
    Indian J Med Res; 1990 May; 91():182-4. PubMed ID: 2397938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lomefloxacin hydrochloride (Maxaquin), a long-acting fluoroquinolone (information for specialists)].
    Kuznetsovoĭ SM
    Antibiot Khimioter; 1998; 43(2):40-1. PubMed ID: 9551172
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoroquinolones in the treatment of human infection: the role of temafloxacin.
    Am J Med; 1991 Dec; 91(6A):1S-171S. PubMed ID: 1662876
    [No Abstract]   [Full Text] [Related]  

  • 40. Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions.
    Borcherding SM; Stevens R; Nicholas RA; Corley CR; Self T
    J Fam Pract; 1996 Jan; 42(1):69-78. PubMed ID: 8537808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.